Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study.

Liling Qiu Ping Ling Daizhi Yang Sihui Luo Xueying Zheng Hua Liang Yong Yuan Ganxiong Liang Wen Xu Bin Yao Jianping Weng Jian-Ping Weng

Published in: Journal of diabetes (2020)

Metformin is initiated more in T1DM patients with dyslipidemia or higher BMI in current practice in China. The addition of metformin is effective in maintaining weight and reducing the insulin dosage without improving glycemic control in patients with T1DM.

Keyphrases

glycemic control
type diabetes
weight loss
blood glucose
current status
body mass index
insulin resistance
healthcare
weight gain
primary care
cardiovascular disease
mesenchymal stem cells
stem cells
body weight
metabolic syndrome
replacement therapy